Payer Partnerships Freespira targets health plans, self-insured employers, and the VA; the at-home, drug-free device has demonstrated clinical impact on panic disorder and PTSD while offering potential cost savings through reduced medical utilization. Sales opportunities include payer coverage expansion and ROI-driven pilots, leveraging existing partnerships like Lovell Government Services and Security Health Plan to scale adoption.

Veteran Focus There is a strong veteran-oriented channel, evidenced by a Lovell Government Services partnership expanding access for Veterans. The company should pursue VA procurement opportunities and hospital partnerships serving veteran populations, using the FDA clearance and clinical results as proof points to win contracts and pilot programs.

Innovation Edge Freespira is advancing with a fifth-generation device featuring sensor integration and a unified display, improving usability and patient adherence. This innovation differentiates Freespira in the digital therapeutics space and creates upsell opportunities with clinics, hospitals, and payer networks seeking cutting-edge at-home solutions.

Credibility Channel Recognition as Fast Company's Most Innovative Company in 2023, plus ongoing payer and health-system partnerships, add credibility that can shorten procurement cycles. Use this pedigree in marketing and RFP responses, and develop reference cases to accelerate deals with insurers and healthcare providers.

Growth Readiness With a lean team and mid-range revenue, Freespira's device-based therapy offers scalable growth through payer channels and health-system partnerships. A sales strategy that includes channel partnerships, distributor agreements, broker networks, and co-marketing with existing partners can expand reach to more employers, plans, and government programs.